ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

10 Fibro-Friendly Foods with a Bonus: Beautiful Skin

Fight Back! Win the War Being Waged Against Your Immune System

Studies Show that Magnesium L-threonate Improves Brain Plasticity, Leading to Direct and Significant...

Clary Sage Oil May Be Pricey, but Its Benefits Are Priceless

Component of red wine, grapes can help to reduce inflammation, study finds

Poly MVA: A Novel Therapy for Increasing Energy, Repairing DNA, and Promoting Overall Health

Pumpkin Pie Turmeric Breakfast Smoothie - Vegan + Gluten-Free

Vitamin D supplementation extends life in mouse model of Huntington's disease

What’s Fenugreek Good For?

Omega-3 fatty acid stops known trigger of lupus

Print Page
Email Article

Nationwide Trial Recruiting 1,350 High Risk Individuals for HIV Vaccine Study

  [ 10 votes ]   [ Discuss This Article ] • September 19, 2010

3-year trial will test non-virus vaccine’s ability to prevent the onset of AIDS in healthy people who subsequently become infected with HIV.

Along with other teams across the US, researchers at University of Texas Southwestern Medical Center are recruiting individuals at high risk of contracting HIV for a nationwide clinical trial to investigate whether the combination of two potential vaccines will stimulate an immune response to the virus that causes AIDS.

The study is funded by the HIV Vaccine Trials Network (HVTN) and the National Institute of Allergy and Infectious Diseases.

“We hope that this trial will help us better understand how the immune system may work to prevent HIV/AIDS,” said infectious diseases researcher Mamta Jain, MD, MPH, principal investigator of the UT Southwestern effort. “It is with this better understanding of the immune system that we may ultimately find a vaccine that may prevent HIV infection.”

Dr. Jain stressed that participants cannot contract HIV from the vaccine.

“This trial may help us better understand why some people develop AIDS and others don’t. If you could prevent people from getting sick from AIDS, that’s a tremendous accomplishment.”

Both components of the combined vaccine, which is designed to produce immune cells called T cells and antibody responses against HIV, have been found safe when tested in animals and hundreds of humans in previous clinical trials.

“The vaccine is composed of man-made proteins that are found in HIV, not the HIV virus itself,” Dr. Jain said. “The vaccine cannot cause infection.”

HIV is transmitted predominantly by unprotected sexual contact with an infected partner. Although huge leaps in scientific knowledge over the past three decades have led to a much better understanding of the complex disease, preventing its spread has proved much more challenging.

Today, someone in the U.S. becomes infected with HIV every 10 minutes.

The study, known as the HVTN 505 study, is designed to determine whether this new combo-vaccine will reduce the HIV viral load of people who subsequently become infected with HIV, preventing the onset of AIDS.

For the clinical trial, 1,350 volunteers nationwide will be assigned randomly to receive either the combination vaccine or a placebo. Forty to 50 people will participate at UT Southwestern; the next closest site is 650 miles from Dallas at the Alabama Vaccine Research Clinic in Birmingham.

“This is the only HIV vaccine trial in the country enrolling participants, so we are very excited to be part of this endeavor,” Dr. Jain said.

Participants in the three-year study:

• Will receive three shots of the research vaccine or a placebo, plus a booster shot, within the first six months.

• And will then return every three months for an HIV test, interview and risk-reduction counseling.

Investigators are seeking to enroll healthy, non-HIV-infected men ages 18 to 45 who have sex with men, and transgender women who have sex with men.

For more information about the clinical trial:

• Call 214-590-0610 or 214-590-0603,

• Or visit


Source: University of Texas, Southwestern (Dallas) news release, Sep 10, 2010

Post a Comment

Featured Products From the ProHealth Store
FibroSleep™ Energy NADH™ 12.5mg Ultra EPA  - Fish Oil

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

Natural Pain Relief Supplements

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Carry a Massage Therapist in Your Pocket Carry a Massage Therapist in Your Pocket
Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial
Vitamin E: Super Antioxidant We Only Thought We Knew Vitamin E: Super Antioxidant We Only Thought We Knew
How Glutathione Can Save Your Life How Glutathione Can Save Your Life
When a Negative is Positive - Goodnighties Recovery Sleepwear When a Negative is Positive - Goodnighties Recovery Sleepwear

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map